Serial 97095713
Live / Registered — Registered (as of 30 Jul 2024)
What this means for you
Registered since 30 Jul 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97095713
- Registration number
- 7459467
- Mark type
- Design / logo
- Filed
- 27 Oct 2021
- Published for opposition
- 14 May 2024
- Registered
- 30 Jul 2024
- Attorney of record
- Karl M. Zielaznicki, Esq.
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the field of autoimmunology, bacterial infection diseases and disorders, cardiology, central and peripheral nervous systems diseases and disorders, diabetes, endocrinology, haematology, hormonal diseases and disorders, gastroenterology, gout, immunology, infectious diseases and disorders, inflammatory diseases and disorders, musculoskeletal diseases and disorders, neuroscience, oncology, pain management, respiratory diseases and disorders, urological diseases and disorders, viral diseases and disorders, rare diseases namely, autoimmune rare diseases, bacterial infectious rare diseases, cardiological rare diseases, central and peripheral nervous systems rare diseases, diabetes rare diseases, endocrinological rare diseases, haematological rare diseases, hormonally originating rare diseases, gastroenterological rare diseases, gout rare diseases, infectious rare diseases, inflammatory rare diseases, musculoskeletal rare diseases, genetic rare diseases, neurological rare diseases, oncological cancer rare diseases, respiratory rare diseases, urological and kidney rare diseases, viral rare diseases; and pharmaceutical products and preparations containing plasma-derived therapies for treating immunodeficiencies, neuroimmunology, hematology, pulmonology, and rare diseases, namely, autoimmune rare diseases, bacterial infectious rare diseases, cardiological rare diseases, central and peripheral nervous systems rare diseases, diabetes rare diseases, endocrinological rare diseases, haematological rare diseases, hormonally originating rare diseases, gastroenterological rare diseases, gout rare diseases, infectious rare diseases, inflammatory rare diseases, musculoskeletal rare diseases, genetic rare diseases, neurological rare diseases, oncological cancer rare diseases, respiratory rare diseases, urological and kidney rare diseases, viral rare diseases; Pharmaceutical preparations in the field of vaccines, namely, vaccines for human use
Owner
- Takeda Pharmaceutical Company Limited, Osaka, JP
- Takeda Pharmaceutical Company Limited, Osaka, JP
- Takeda Pharmaceutical Company Limited, Osaka, JP
Prior registrations
Prosecution history
- 30 Jul 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Jul 2024 — REGISTERED-PRINCIPAL REGISTER
- 14 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 14 May 2024 — PUBLISHED FOR OPPOSITION
- 24 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 05 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 05 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 05 Mar 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 26 Feb 2024 — APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
- 26 Feb 2024 — APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
- 29 Nov 2023 — NOTIFICATION OF SUBSEQUENT FINAL EMAILED
- 29 Nov 2023 — SUBSEQUENT FINAL EMAILED
- 29 Nov 2023 — SUBSEQUENT FINAL REFUSAL WRITTEN
- 11 Oct 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED